Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome (2016)

  • Authors:
  • USP affiliated authors: COSTA, SILVIA FIGUEIREDO - FM ; LEVIN, ANNA SARA SHAFFERMAN - FM
  • USP Schools: FM; FM
  • DOI: 10.1186/s12879-016-1979-z
  • Subjects: ENTEROBACTERIACEAE; RESISTÊNCIA MICROBIANA ÀS DROGAS; ESTUDOS PROSPECTIVOS; INFECÇÕES BACTERIANAS GRAM-NEGATIVAS
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1186/s12879-016-1979-z (Fonte: oaDOI API)
    • Este periódico é de acesso aberto
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: hybrid
    • Licença: cc-by
    Versões disponíveis em Acesso Aberto do: 10.1186/s12879-016-1979-z (Fonte: Unpaywall API)

    Título do periódico: BMC Infectious Diseases

    ISSN: 1471-2334

    • Melhor URL em Acesso Aberto:
      • Página do artigo
      • Evidência: open (via page says license)
      • Licença: cc-by
      • Versão: publishedVersion
      • Tipo de hospedagem: publisher


    • Outras alternativas de URLs em Acesso Aberto:
        • Página do artigo
        • Evidência: open (via page says license)
        • Licença: cc-by
        • Versão: publishedVersion
        • Tipo de hospedagem: publisher


        • Página do artigo
        • Evidência: oa journal (via doaj)
        • Licença: cc-by
        • Versão: publishedVersion
        • Tipo de hospedagem: publisher




        • Página do artigo
        • Link para o PDF
        • Evidência: oa repository (via OAI-PMH title and last author match)
        • Licença: cc-by
        • Versão: publishedVersion
        • Tipo de hospedagem: repository


        • Página do artigo
        • Evidência: oa repository (via pmcid lookup)
        • Licença:
        • Versão: publishedVersion
        • Tipo de hospedagem: repository


    Informações sobre o Citescore
  • Título: BMC Infectious Diseases

    ISSN: 1471-2334

    Citescore - 2017: 2.86

    SJR - 2017: 1.576

    SNIP - 2017: 1.187


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM2798998-10BCSEP^143^2016
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CARRILHO, Claudia M. D. de Maio; OLIVEIRA, Larissa Marques de; GAUDERETO, Juliana; et al. A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome. BMC Infectious Diseases, London, v. 16, n. 629, p. 9 , 2016. Disponível em: < http://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-016-1979-z > DOI: 10.1186/s12879-016-1979-z.
    • APA

      Carrilho, C. M. D. de M., Oliveira, L. M. de, Gaudereto, J., Perozin, J. S., Urbano, M. R., Camargo, C. H., et al. (2016). A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome. BMC Infectious Diseases, 16( 629), 9 . doi:10.1186/s12879-016-1979-z
    • NLM

      Carrilho CMD de M, Oliveira LM de, Gaudereto J, Perozin JS, Urbano MR, Camargo CH, Grion CMC, Levin ASS, Costa SF. A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome [Internet]. BMC Infectious Diseases. 2016 ; 16( 629): 9 .Available from: http://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-016-1979-z
    • Vancouver

      Carrilho CMD de M, Oliveira LM de, Gaudereto J, Perozin JS, Urbano MR, Camargo CH, Grion CMC, Levin ASS, Costa SF. A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome [Internet]. BMC Infectious Diseases. 2016 ; 16( 629): 9 .Available from: http://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-016-1979-z

    Referências citadas na obra
    Adler A, Carmeli Y. Dissemination of the Klebsiella pneumoniae carbapenemase in the health care settings: tracking the trails of an elusive offender. MBio. 2011;2(6):10,1128;mBio.00280,11
    Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumonia carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9(4):228–36.
    Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13:785–96.
    Daikos GL, Tsaousi S, Tzouvelekis S, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother. 2014;58(4):2322–8.
    Bulik CC, Nicolau DP. Double-carbapenem therapy for carbapenemase- producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2011;55(6):3002–4.
    Marchaim D, Chopra T, Perez F, et al. Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit Medical Center. Infect Control Hosp Epidemiol. 2011;32(9):861–71.
    Mezzatesta ML, Gona F, Caio C, et al. Outbreak of KPC-3-producing and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian Hospitals. Clin Microbiol Infect. 2011;17(9):1444–7.
    Correa L, Martino MDV, Siqueira I, et al. A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant Klebsiella pneumoniae infection. BMC Infect Dis. 2013;13:80.
    Kontopidou F, Giamarellou H, Katerelos P, et al. Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care in Greece: a multi-centre study on clinical outcome and therapeutic options. Clin Microbiol Infect. 2014;20(2):117–23.
    Grundmann H, Livermore DM, Giske CK, et al. Carbapenem non- susceptible Enterobacteriaceae in Europe: conclusions from a meeting of a national experts. Euro Surveill. 2010;15(46):1-13.
    de Oliveira MS, de Assis DB, Freire MP, et al. Treatment of KPC-producing Enterobacteriacea: suboptimal efficacy of polymyxins. Clin Microbiol Infect. 2015;21(2):179.e1–7.
    Capone A, Giannella M, Fortini D, et al. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect. 2013;19:E23–30.
    Humphries RM, Keledesis T, Bard JD, et al. Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high dose tigecycline and colistin. J Med Microbiol. 2010;59:1383–6.
    van Duin D, Kaye KS, Neuner EA, Bonomo RA. Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes. Diagn Microbiol Infect Dis. 2013;75(2):115–20.
    Lee GC, Burgess DS. Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports. Ann Clin Microbiol Antimicrob. 2012;11:32–40.
    Horan T, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309–32.
    Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250–6.
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.
    Institute CLS. Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement, M100-S20. CLSI: Wayne (PA); 2012.
    European Committee on Antimicrobial Susceptibility Testing (Eucast). 2012.
    Bradford PA, Bratu C, Urban M, et al. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactases in New York City. Clin Infect Dis. 2004;39:55–60.
    Chen Y, Zhou Z, Jiang Y, Yu Y. Emergence of NDM-1-producing Acinetobacter baumannii in China. J Antimicrob Chemother. 2011;66:1255–9.
    Monteiro J, Widen RH, Pignatari ACC. Rapid detection of carbapenemase genes by multiplex real time PCR. J Antimicrob Chemother. 2012;67:907–9.
    Pfaller MA. Chromosomal restriction fragment analysis by pulsed-field gel electrophoresis. In: Isemberg HD, editor. Clinical microbiology procedures handbook. Washington: American Society for Microbiology; 1993.
    Qureshi ZA, Paterson DL, Potoski BA, et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother. 2012;56(4):2108–13.
    Souli M, Galani I, Antoniadou A, et al. An outbreak of infection due to β-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek university hospital. Clin Infect Dis. 2010;50:364–73.
    Tumbarello M, Trecarichi EM, De Rosa FG, et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicenter study. J Antimicrob Chemother. 2015;70(7):2133–43.
    Zarkotou O, Pournaras S, Tselioti P, et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect. 2011;17:1798–803.
    Ceccarelli G, Falconi M, Giordano A. Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin resistant KPC-producing K. pneumoniae. Antimicrob Agents Chemother. 2013;57(6):2900–1.
    Cicora F, Mos F, Paz M, Allende NG, Roberti J. Infections with blaKPC-2-producing Klebsiella pneumoniae in renal transplant patients: a retrospective study. Transplant Proc. 2013;45(9):3389–93.